American International Group, Inc. Kal Vista Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$11.07 - $16.04 $464 - $673	42 Added 0.27%	15,431 $183,000
Q4 2023 Feb 13, 2024	BUY	$7.58 - $12.25 $23,490 - $37,962	3,099 Added 25.22%	15,389 $188,000
Q3 2023 Nov 13, 2023	BUY	$8.95 - $11.35 $3,911 - $4,959	437 Added 3.69%	12,290 $118,000
Q2 2023 Aug 04, 2023	BUY	$7.73 - $10.57 $301 - $412	39 Added 0.33%	11,853 $106,000
Q1 2023 May 12, 2023	BUY	$6.3 - $8.39 $1,480 - $1,971	235 Added 2.03%	11,814 $92,000
Q4 2022 Feb 10, 2023	SELL	$4.2 - $14.24 $176 - $598	-42 Reduced 0.36%	11,579 $78,000
Q3 2022 Nov 14, 2022	BUY	$9.85 - $16.83 $1,625 - $2,776	165 Added 1.44%	11,621 $169,000
Q2 2022 Aug 12, 2022	BUY	$8.16 - $15.1 $2,749 - $5,088	337 Added 3.03%	11,456 $113,000
Q1 2022 May 13, 2022	SELL	$11.2 - $16.97 $8,758 - $13,270	-782 Reduced 6.57%	11,119 $164,000
Q4 2021 Feb 11, 2022	BUY	$12.36 - $18.28 $12,619 - $18,663	1,021 Added 9.38%	11,901 $157,000
Q3 2021 Nov 12, 2021	SELL	$17.11 - $24.49 $4,431 - $6,342	-259 Reduced 2.33%	10,880 $190,000
Q2 2021 Aug 13, 2021	BUY	$23.12 - $29.91 $786 - $1,016	34 Added 0.31%	11,139 $267,000
Q1 2021 May 07, 2021	BUY	$14.69 - $42.57 $38,473 - $111,490	2,619 Added 30.86%	11,105 $285,000
Q4 2020 Feb 12, 2021	BUY	$12.88 - $19.47 $4,276 - $6,464	332 Added 4.07%	8,486 $161,000
Q3 2020 Nov 04, 2020	SELL	$9.83 - $13.99 $1,828 - $2,602	-186 Reduced 2.23%	8,154 $103,000
Q2 2020 Aug 12, 2020	BUY	$6.75 - $12.89 $5,859 - $11,188	868 Added 11.62%	8,340 $101,000
Q1 2020 May 04, 2020	SELL	$5.8 - $18.56 $2,499 - $7,999	-431 Reduced 5.45%	7,472 $57,000
Q4 2019 Feb 05, 2020	BUY	$10.31 - $17.81 $5,484 - $9,474	532 Added 7.22%	7,903 $141,000
Q3 2019 Nov 08, 2019	SELL	$11.6 - $21.67 $580 - $1,083	-50 Reduced 0.67%	7,371 $86,000
Q2 2019 Aug 13, 2019	BUY	$18.44 - $30.89 $136,843 - $229,234	7,421 New	7,421 $164,000

Others Institutions Holding KALV

# of Institutions

121

Shares Held

47.7M

Call Options Held

71.8K

Put Options Held

26.3K

Vr Adviser, LLC New York, NY

6.25M
Shares

$72.4 Million
8.08% of portfolio
Tang Capital Management LLC San Diego, CA

4.22M
Shares

$48.9 Million
6.07% of portfolio
Suvretta Capital Management, LLC New York, NY

4.19M
Shares

$48.5 Million
2.06% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.69M
Shares

$42.7 Million
2.56% of portfolio
Capital World Investors Los Angeles, CA

3.23M
Shares

$37.4 Million
0.01% of portfolio

View Full List

About KalVista Pharmaceuticals, Inc.

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $285M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

More about KALV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account